This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Bio-Techne Corp. slid 4.0% to $69.92 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.7% to 6,066.44 and the Dow Jones Industrial Average rising 0.4% to 44,470.41.
This was the stock's third consecutive day of losses.
Bio-Techne Corp. closed 18.3% below its 52-week high of $85.57, which the company achieved on May 15th.
The stock underperformed when compared to some of its competitors, as Amgen Inc. rose 0.4% to $294.79, Charles River Laboratories International Inc. fell 2.4% to $159.89, and BioMarin Pharmaceutical Inc. fell 0.67% to $63.50.
Trading volume totaled 2.9 million, compared to the 50-day average of 934,927.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 10, 2025 16:42 ET (21:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.